关注
Tibor Casian
标题
引用次数
引用次数
年份
The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with …
K Ilyés, NK Kovács, A Balogh, E Borbás, B Farkas, T Casian, G Marosi, ...
European Journal of Pharmaceutical Sciences 129, 110-123, 2019
1382019
Development, validation and comparison of near infrared and Raman spectroscopic methods for fast characterization of tablets with amlodipine and valsartan
T Casian, A Reznek, AL Vonica-Gligor, J Van Renterghem, T De Beer, ...
Talanta 167, 333-343, 2017
482017
Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms
T Casian, E Borbás, K Ilyés, B Démuth, A Farkas, Z Rapi, C Bogdan, ...
International journal of pharmaceutics 569, 118593, 2019
412019
3D floating tablets: Appropriate 3D design from the perspective of different in vitro dissolution testing methodologies
K Ilyés, A Balogh, T Casian, T Igricz, E Borbás, B Démuth, P Vass, ...
International journal of pharmaceutics 567, 118433, 2019
412019
QbD for pediatric oral lyophilisates development: Risk assessment followed by screening and optimization
T Casian, S Iurian, C Bogdan, L Rus, M Moldovan, I Tomuta
Drug Development and Industrial Pharmacy 43 (12), 1932-1944, 2017
402017
Fluidised bed granulation of two APIs: QbD approach and development of a NIR in-line monitoring method
A Gavan, S Iurian, T Casian, A Porfire, S Porav, I Voina, A Oprea, I Tomuta
Asian Journal of Pharmaceutical Sciences 15 (4), 506-517, 2020
352020
Challenges and opportunities of implementing data fusion in process analytical technology—a review
T Casian, B Nagy, B Kovács, DL Galata, E Hirsch, A Farkas
Molecules 27 (15), 4846, 2022
322022
QbD guided development of immediate release FDM-3D printed tablets with customizable API doses
AG Crișan, S Iurian, A Porfire, LM Rus, C Bogdan, T Casian, RC Lucacel, ...
International journal of pharmaceutics 613, 121411, 2022
282022
Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis
T Casian, C Bogdan, D Tarta, M Moldovan, I Tomuta, S Iurian
Journal of pharmaceutical and biomedical analysis 152, 47-56, 2018
262018
Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development
VF Rauca, L Vlase, T Casian, A Sesarman, AM Gheldiu, A Mocan, ...
Frontiers in Pharmacology 10, 334, 2019
232019
Videometric mass flow control: A new method for real-time measurement and feedback control of powder micro-feeding based on image analysis
L Madarász, Á Köte, M Gyürkés, A Farkas, B Hambalkó, H Pataki, G Fülöp, ...
International Journal of Pharmaceutics 580, 119223, 2020
192020
Combination of PAT and mechanistic modeling tools in a fully continuous powder to granule line: Rapid and deep process understanding
A Domokos, É Pusztai, L Madarász, B Nagy, M Gyürkés, A Farkas, ...
Powder Technology 388, 70-81, 2021
172021
Data fusion strategies for performance improvement of a Process Analytical Technology platform consisting of four instruments: An electrospinning case study
T Casian, A Farkas, K Ilyés, B Démuth, E Borbás, L Madarász, Z Rapi, ...
International Journal of Pharmaceutics 567, 118473, 2019
172019
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
L Luput, A Sesarman, A Porfire, M Achim, D Muntean, T Casian, L Patras, ...
Cancer science 111 (4), 1344-1356, 2020
162020
Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry
AL Vonica-Gligor, T Casian, A Reznek, I Tomuta, F Gligor
Farmacia 63 (3), 381-387, 2015
152015
Near Infra-Red spectroscopy for content uniformity of powder blends–Focus on calibration set development, orthogonality transfer and robustness testing
T Casian, S Iurian, A Gavan, C Revnic, S Porav, A Porfire, L Vlase, ...
Talanta 188, 404-416, 2018
142018
Definition and validation of the Design Space for co-milled nasal powder containing nanosized lamotrigine
P Gieszinger, I Tomuta, T Casian, C Bartos, P Szabó-Révész, R Ambrus
Drug Development and Industrial Pharmacy 44 (10), 1622-1630, 2018
132018
In-depth understanding of granule compression behavior under variable raw material and processing conditions
T Casian, S Iurian, A Gâvan, A Porfire, AL Pop, S Crișan, AM Pușcaș, ...
Pharmaceutics 14 (1), 177, 2022
122022
Multivariate feed forward process control and optimization of an industrial, granulation based tablet manufacturing line using historical data
R Mathe, T Casian, I Tomuţă
International Journal of Pharmaceutics 591, 119988, 2020
122020
Epilobium Species: From Optimization of the Extraction Process to Evaluation of Biological Properties
AM Vlase, A Toiu, I Tomuță, L Vlase, D Muntean, T Casian, I Fizeșan, ...
Antioxidants 12 (1), 91, 2022
92022
系统目前无法执行此操作,请稍后再试。
文章 1–20